Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
37.67
+1.68 (4.67%)
Aug 13, 2025, 4:00 PM - Market closed
Xenon Pharmaceuticals Employees
As of December 31, 2024, Xenon Pharmaceuticals had 327 total employees, including 316 full-time and 11 part-time employees. The number of employees increased by 68 or 26.25% compared to the previous year.
Employees
327
Change (1Y)
68
Growth (1Y)
26.25%
Revenue / Employee
$22,936
Profits / Employee
-$850,850
Market Cap
2.90B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XENE News
- 1 day ago - Xenon Pharmaceuticals: Pushing Azetukalner Towards Finish Line With Phase 3 2026 Data Release - Seeking Alpha
- 2 days ago - Xenon Pharmaceuticals Inc. (XENE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Xenon Reports Second Quarter 2025 Financial Results & Business Update - GlobeNewsWire
- 10 days ago - Xenon to Report Q2 2025 Financial Results on August 11, 2025 - GlobeNewsWire
- 12 days ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Xenon Joins the Russell 3000® and Russell 2000® Indexes - GlobeNewsWire
- 7 weeks ago - Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire